Importance of Blood Pressure Monitoring in Colorectal Cancer Patients Treated with Bevacizumab: the Current Situation

Background: Hypertension associated with bevacizumab (Bev) is a well-known adverse drug reaction. However, we tend to overlook the symptom as other adverse drug events are induced by chemotherapy combined with Bev. In order to highlight the current issues in our hospital on blood pressure monitoring during Bev treatment we conducted this study.